WHO approves Moderna COVID-19 vaccine |
The World Health Organisation has given the go-ahead for emergency use of Moderna`s COVID-19 vaccine for emergency use. The mRNA vaccine from the USA manufacturer joins vaccines from AstraZeneca, Pfizer-BioNTech, and Johnson & Johnson in receiving the WHO`s emergency use listing. WHO`s CEO Stephane Bancel said similar approvals for China`s Sinopharm and Sinovac vaccines are expected in the coming days and weeks. The green light for Moderna`s vaccine, announced on 2nd May, took many months because of delays that WHO faced in getting data from the manufacturer. Many countries without their own advanced medical regulatory and assessment offices rely on the WHO listing to decide whether to use vaccines. UN children`s agency UNICEF also uses the listing to deploy vaccines in an emergency like the pandemic. The announcement, however, wasn`t likely to have an immediate impact on the supplies of Moderna`s vaccine for the developing world. The company struck supply agreements with many developed countries, which have already received millions of doses.
|
|
|
|